scispace - formally typeset
R

Robert Mabry

Researcher at ZymoGenetics

Publications -  23
Citations -  1129

Robert Mabry is an academic researcher from ZymoGenetics. The author has contributed to research in topics: Antibody & Monoclonal antibody. The author has an hindex of 12, co-authored 21 publications receiving 1081 citations. Previous affiliations of Robert Mabry include Dartmouth College & University of Texas at Austin.

Papers
More filters
Journal ArticleDOI

Isolation of engineered, full-length antibodies from libraries expressed in Escherichia coli.

TL;DR: In this article, the authors describe facile isolation of full-length IgG antibodies from combinatorial libraries expressed in E. coli, where heavy and light chains are secreted into the periplasm, where they assemble into aglycosylated IgGs that are captured by an Fc-binding protein that is tethered to the inner membrane.
Journal ArticleDOI

Isolation and expression of recombinant antibody fragments to the biological warfare pathogen Brucella melitensis.

TL;DR: The isolated phage antibodies were shown to be highly specific to B. melitensis and did not recognize Yersinia pseudotuberculosis in contrast to the existing diagnostic monoclonal YST 9.2.1.
Journal ArticleDOI

Five birds, one stone: neutralization of α-hemolysin and 4 bi-component leukocidins of Staphylococcus aureus with a single human monoclonal antibody.

TL;DR: It is found that a single cross-reactive antibody prevented lysis of human phagocytes, epithelial and red blood cells induced by α-hemolysin and leukocidins in vitro, and therefore had superior effectiveness compared to α- hemolysin specific antibodies to protect from the combined cytolytic effect of secreted S. aureus toxins.
Journal ArticleDOI

Detection of anthrax toxin in the serum of animals infected with Bacillus anthracis by using engineered immunoassays

TL;DR: Simple anthrax toxin detection ELISAs could prove useful in the evaluation of potential therapies and possibly as a clinical diagnostic to complement other strategies for the rapid identification of B. anthracis infection.
Patent

Il-17 and il-23 antagonists and methods of using the same

TL;DR: In this paper, the authors proposed a method for blocking, inhibiting, reducing, antagonizing or neutralizing the activity of IL-17, IL-23 via it's p19 subunit.